IPO
SEBI clears Molbio Diagnostics for IPO
By Startup Enthusiast ·
- Date
- Company
- Molbio Diagnostics
- What it does
- Goa diagnostics maker
- Kind
- IPO
- Stage
- IPO approval
- Based in
- Goa
What they do
Market regulator SEBI cleared Molbio Diagnostics to launch its initial public offering, with its observations published in December 2025
What happened
The Goa-based molecular diagnostics company received the approval together with logistics firm LEAP India, which has a much larger issue planned
Why it matters
The approval is a key step before the company can set a price band and open its issue to investors
The details
- SEBI gave its go-ahead for the Molbio Diagnostics public issue.
- The observations were published in December 2025.
- LEAP India received its approval at the same time.
- The nod came months after the draft papers were filed.
More on Molbio Diagnostics
- Motilal Oswal fund sells 2% of Molbio1 October 2026 · Stake sale · ₹306 Cr
- Molbio Diagnostics lists at 21% premium on exchanges17 August 2026 · IPO · Rs 939.7 crore
- Molbio raises Rs 281.5 crore from anchors7 August 2026 · Funding · ₹281.5 Cr
- Molbio posts Rs 1,020 crore FY25 revenue1 September 2025 · Results